*9.2.2 HIV*

Laboratories must follow HIV patients for the risk of infection or reactivation, when the count of linfocitos CD4 is less than 150/mm3. Therefore, the serology results are a complement when an increase of the titer of IgG and IgM appears. If treatment responds favorably in seroreactive patients, it also reinforces diagnosis [24–27].
